CytoMed Therapeutics Limited (GDTC) Net margin 2024–2025
CytoMed Therapeutics Limited (GDTC) net profit margin by fiscal year — reported net income divided by reported revenue.
-1227.1%FY2025 · since FY2024: -3621.1% → -1227.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1227.1% | +2394.0 pp |
| FY2024 | -3621.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More GDTC financial trends
GDTC RevenueGDTC Net incomeGDTC Gross profitGDTC Gross marginGDTC Operating incomeGDTC Operating marginGDTC Operating cash flowGDTC Free cash flowGDTC Capital expendituresGDTC Return on equityGDTC Stock buybacksGDTC Dividends paidGDTC Total assetsGDTC Total liabilitiesGDTC Shareholders’ equityGDTC overview →